Patent · US Active

ST2L antibody antagonists

US9090694B2 · kind B2 · utility

18Cited by
3References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 13, 2013
Grant dateJul 28, 2015
Priority date
Expiry dateMar 13, 2033

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to ST2L antagonists, polynucleotides encoding the antagonists or fragments thereof, and methods of making and using the foregoing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.